Phase 2 study of targeted intravenous busulfan (IV BU) combined with fractionated total body irradiation (FTBI) and etoposide (VP-16) as preparative regimen for allogeneic peripheral blood stem cell transplant (PBSCT) for patients with poor risk leukemia

Saved in:
Bibliographic Details
Published in:Biology of blood and marrow transplantation 2006-02, Vol.12 (2), p.35-35
Main Authors: Stein, A.S., O’Donnell, M.R., Dagis, A., Krishnan, A., Nademanee, A., Nakamura, R., Parker, P.M., Popplewell, L., Pullarkat, V., Rodriguez, R., Rosenthal, J., Smith, E.P., Snyder, D.S., Spielberger, R., Synold, T., Vora, N., Zain, J., Sarkodee-Adoo, C., Forman, S.J.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1083-8791
1523-6536
DOI:10.1016/j.bbmt.2005.11.108